Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Emerson Perin, MD
Texas Heart Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Seoul National University
Seoul, Jongno-gu, South Korea
- Yonsei University Health System. Severance Cardiovascular Hospital
Seoul, Seodaemun-gu, South Korea
- Ewha Womans University Medical Center
Seoul, YangCheon-ku, South Korea
- Cardiology Pc
Birmingham, Alabama, United States
- Vascular and Interventional Specialist of Orange County
Orange, California, United States
- Northwestern Memorial Hospital
Chicago, Illinois, United States
- St. Vincent Medical Group
Indianapolis, Indiana, United States
- Boston University School of Medicine
Boston, Massachusetts, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Saint Louis University
St Louis, Missouri, United States
- Unc School of Medicine
Chapel Hill, North Carolina, United States
- Jobst Vascular
Toledo, Ohio, United States
- University of Oklahoma Hsc
Oklahoma City, Oklahoma, United States
- Texas Heart Institute
Houston, Texas, United States
- the Methodist Hospital
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Jul 2010
- Primary completion
- 5 Aug 2013
- Completion
- 17 Nov 2023
- Last update posted
- 6 Oct 2025
- Registered enrollment
- 52
- Registry id
- NCT01064440
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.